Bolt Biotherapeutics, Inc. (BOLT)
4.56
+0.13
(+2.93%)
USD |
NASDAQ |
Jun 11, 10:07
Bolt Biotherapeutics Total Assets (Quarterly) : 48.03M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 48.03M |
| December 31, 2025 | 62.40M |
| September 30, 2025 | 65.05M |
| June 30, 2025 | 75.50M |
| March 31, 2025 | 85.86M |
| December 31, 2024 | 99.63M |
| September 30, 2024 | 109.33M |
| June 30, 2024 | 124.18M |
| March 31, 2024 | 142.89M |
| December 31, 2023 | 159.78M |
| September 30, 2023 | 175.36M |
| June 30, 2023 | 190.70M |
| March 31, 2023 | 206.18M |
| Date | Value |
|---|---|
| December 31, 2022 | 227.81M |
| September 30, 2022 | 245.50M |
| June 30, 2022 | 260.24M |
| March 31, 2022 | 282.79M |
| December 31, 2021 | 307.72M |
| September 30, 2021 | 333.55M |
| June 30, 2021 | 347.07M |
| March 31, 2021 | 324.64M |
| December 31, 2020 | 46.54M |
| September 30, 2020 | 61.74M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 48.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sangamo Therapeutics, Inc. | 59.96M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sarepta Therapeutics, Inc. | 3.179B |
| Anixa Biosciences, Inc. | 15.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.20M |
| Shareholders Equity (Quarterly) | 19.82M |
| Debt to Equity Ratio | 1.125 |
| Current Ratio | 3.507 |
| Net Debt Paydown Yield | 7.48% |